ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628811 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628811; 2) Community: the network communities that were significantly associated with the response to NSC 628811; 3) Molecule: the relationships between components within communities and NSC 628811; 4) MDR: the compounds that were significantly associated with the NSC 628811.

NSC Compound Enrichment Correlation
NSC 737613 Null 0.0102962192514438 0.25641554
NSC 744025 diethyl 2-[4-(5-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypentyl)piperazino]ethylphosphonate 0.0102962192514438 0.4878595
NSC 12198 Dromostanolone Propionate 0.0102962192514439 0.37993544
NSC 12455 Acid Alizarin Red B 0.0102962192514439 0.35516263
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.0102962192514439 0.3597791
NSC 295641 Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester 0.0102962192514439 -0.06285001
NSC 308847 Amonafide 0.0102962192514439 0.18249334
NSC 681637 Camptothecin Derivative 0.0102962192514439 0.20207012
NSC 94600 Camptothecin 0.0102962192514439 0.17536369
NSC 338304 Iron, dichloro[hexahydro-1H-azepine-1-carbothioic acid [1-(2-pyridinyl)ethylidene]hydraziato] 0.0107933723273943 0.26808926
Total:135  Current:45    [First] [Prev] [Next] [Last]